Exposure to tricyclic and selective serotonin reuptake inhibitor antidepressants and the risk of hip fracture.
about
Cause or Effect? Selective Serotonin Reuptake Inhibitors and Falls in Older Adults: A Systematic ReviewBupropion and the risk of sudden death: a self-controlled case-series analysis using The Health Improvement NetworkTreatment considerations for patients with neuropathic pain and other medical comorbidities.Risk of Hip Fracture in Older People Using Selective Serotonin Reuptake Inhibitors and Other Psychoactive Medicines Concurrently: A Matched Case-Control Study in Australia.Developments in post-marketing comparative effectiveness researchUpdate in serotonin and bone.Use of selective serotonin reuptake inhibitors and risk of fracture: a systematic review and meta-analysis.Selective serotonin reuptake inhibitor treatment and risk of fractures: a meta-analysis of cohort and case-control studies.Relationship between use of antidepressants and risk of fractures: a meta-analysis.Antidepressants in the treatment of neuropathic pain.Do Selective Serotonin Reuptake Inhibitors (SSRIs) Cause Fractures?An evaluation of the THIN database in the OMOP Common Data Model for active drug safety surveillance.Medication as a risk factor for falls: critical systematic review.Safety of antidepressants in adults aged under 65: protocol for a cohort study using a large primary care database.Antidepressant use and risk of adverse outcomes in older people: population based cohort study.Antidepressant prescriptions: an acute window for falls in the nursing home.Chronic administration of anticonvulsants but not antidepressants impairs bone strength: clinical implications.Are selective serotonin reuptake inhibitors a secondary cause of low bone density?Pharmacoepidemiology.Effects of selective serotonin reuptake inhibitors on bone health in adults: time for recommendations about screening, prevention and management?SSRIs: bad to the bone?Brains, bones, and aging: psychotropic medications and bone health among older adults.Loss of treatment benefit due to low compliance with bisphosphonate therapy.Use of antidepressant medications and risk of fracture in older womenDepressive symptoms, bone loss, and fractures in postmenopausal women.Measurement Error Case Series Models with Application to Infection-Cardiovascular Risk in OlderPatients on Dialysis.Antidepressants and fracture risk in older adults: a comparative safety analysis.Fractures in users of antidepressants and anxiolytics and sedatives: effects of age and doseDepression and osteoporosis: epidemiology and potential mediating pathways.The complex interplay of depression and falls in older adults: a clinical review.Effect of sertraline on risk of falling in older adults with psychotic depression on olanzapine: results of a randomized placebo-controlled trialEffects of depression and antidepressant medications on hip fracture: A population-based cohort study in Taiwan.Rates of bone loss among women initiating antidepressant medication use in midlifeUse of anti-depressants and the risk of fracture of the hip or femur.Risk of fractures with selective serotonin-reuptake inhibitors or tricyclic antidepressants.Depression as a risk factor for osteoporosis.Predicting risk of osteoporotic fracture in men and women in England and Wales: prospective derivation and validation of QFractureScores.A review of SSRIs and SNRIs in neuropathic pain.Treatments for anxiety and depression in patients with chronic obstructive pulmonary disease: a literature review.Excess risk of hip fractures attributable to the use of antidepressants in five European countries and the USA.
P2860
Q24289445-2C790DEA-6970-49C2-83D2-FB84AF20CBDEQ24678592-F63841C2-1C65-4CB0-83DC-B2FA6C0E4FF4Q33747271-24E8D2B1-66DD-4414-8DF4-C4FD2E093988Q33758585-9E08AA5E-D7DD-4EC4-9E88-62726F1E39BCQ34001867-D467C64E-EF4E-4126-87F9-F1A783D65826Q34113148-32E9ADAD-7991-41A3-AB47-F296AAAD3A4FQ34132829-58676391-D8CA-48F7-9D0D-DE9C9C784F1DQ34214948-26F13F7A-52AE-43DD-AB1C-35768701D953Q34277620-2EB6D66D-A78C-4B55-A041-721D05A11394Q34420689-2E9A1908-CCE7-4CF5-85A0-011EF21F5B0BQ34536565-01496DA9-CF58-4A00-BFC4-24FE260AE7CBQ34553415-716BDCCD-D7D4-4898-A23C-7C35F4FD71ECQ34699352-71A7252E-9FE1-49DD-ADDE-E7CDB7DC2F74Q34714863-E7047C47-31C8-483D-A166-99622D2061A1Q35144173-017D3913-8BDB-41B7-8FA5-DA70FF91798DQ35459551-5ABB3E16-E392-4C95-A6CC-99422E582744Q35813088-5EFA0CC6-9374-4265-A26A-BCA6E083BF67Q35837768-3AF4FEE3-B44B-40EA-956A-D4525B8A416EQ36081506-2D09960E-D5C2-4107-B4C5-A197CBE14041Q36146084-60AB0436-9854-4890-BD0B-FB97F583BD27Q36235126-E3443E8C-8864-4503-9964-43B46364E252Q36427958-FD22C510-F47C-4785-A2E1-8F19934CB308Q36495575-29CC5AC4-5DED-4A17-B9C7-61D6966C3858Q36526151-4D4AC492-BD3D-41E3-94F8-2FE15B1F663FQ36572715-791F7F75-9639-47BE-BE3E-C66717CC9D6BQ36813203-F5666146-4515-44F4-B6E9-9FDEEAE29630Q36817545-FC1FAFC6-0F1F-42D4-B46B-FE3CDF1002E8Q36855935-F7600C30-2135-465D-838C-D53BD95642FBQ36925842-6AE94074-6C96-4A5B-9AD8-7D71B46BA933Q36936093-34F13AA5-C757-4BB7-90DA-14A276F829AFQ37248761-E4C70480-A177-4B96-8D5C-69D47754545CQ37256907-9AF3EFD1-536D-480F-95FE-1B3B83113409Q37275988-7EA3F28F-D2A6-4B28-BD76-D26BF5D65472Q37348729-328F66E3-47F2-451E-B092-160051A24C7EQ37360320-F66C51BA-3B55-4612-B91D-2AF1C6243D15Q37393313-0AAF520B-BCD1-464A-8420-5BC812F87F4AQ37427052-77E7FA29-80C9-4E90-B1D2-B44C1B920BA4Q37773988-78E5914B-DD68-4625-B11C-C74A9B08EDBAQ37981714-3C2CA113-1CFA-4934-8A91-D0FC5AB9E3DFQ38180612-446BFD85-D2FD-4650-8E2E-4437680FBE82
P2860
Exposure to tricyclic and selective serotonin reuptake inhibitor antidepressants and the risk of hip fracture.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Exposure to tricyclic and sele ...... and the risk of hip fracture.
@en
Exposure to tricyclic and sele ...... and the risk of hip fracture.
@nl
type
label
Exposure to tricyclic and sele ...... and the risk of hip fracture.
@en
Exposure to tricyclic and sele ...... and the risk of hip fracture.
@nl
prefLabel
Exposure to tricyclic and sele ...... and the risk of hip fracture.
@en
Exposure to tricyclic and sele ...... and the risk of hip fracture.
@nl
P2093
P356
P1476
Exposure to tricyclic and sele ...... and the risk of hip fracture.
@en
P2093
Anne Tattersfield
Chris Smith
Paddy Farrington
Richard Hubbard
P356
10.1093/AJE/KWG114
P407
P50
P577
2003-07-01T00:00:00Z